RT Journal Article
T1 Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
A1 Hox, Valerie
A1 Lourijsen, Evelijn
A1 Jordens, Arnout
A1 Aasbjerg, Kristian
A1 Agache, Ioana
A1 Alobid, Isam
A1 Bachert, Claus
A1 Boussery, Koen
A1 Campo, Paloma
A1 Fokkens, Wytske
A1 Hellings, Peter
A1 Hopkins, Claire
A1 Klimek, Ludger
A1 Mäkelä, Mika
A1 Mösges, Ralph
A1 Mullol, Joaquim
A1 Pujols, Laura
A1 Rondon, Carmen
A1 Rudenko, Michael
A1 Toppila-Salmi, Sanna
A1 Scadding, Glenis
A1 Scheire, Sophie
A1 Tomazic, Peter-Valentin
A1 Van Zele, Thibaut
A1 Wagemann, Martin
A1 van Boven, Job F. M.
A1 Gevaert, Philippe
K1 Glucocorticosteroids
K1 Rhinitis
K1 Rhinosinusitis
K1 Glucocorticoides
K1 Rinitis
K1 Sinusitis
K1 Pólipos nasales
K1 Corticoesteroides
AB Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.
PB BioMed Central, Springer Nature
YR 2020
FD 2020-01-03
LK http://hdl.handle.net/10668/3699
UL http://hdl.handle.net/10668/3699
LA en
NO Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020 Jan 3;10:1
DS RISalud
RD Apr 7, 2025